Top-News

West Pharmaceutical Services Aktie News

Aktie
WKN:  864330 ISIN:  US9553061055 US-Symbol:  WST Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
280,05 $
-1,72 $
-0,61%
240,54 € 19:05:22 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,29 Mrd. €
Streubesitz
1,12%
KGV
48,96
Dividende
0,22 $
Dividendenrendite
0,08%
neu: Nachhaltigkeits-Score
32 %
Index-Zuordnung
S&P 500
Weiter abwärts? Short handeln - Jetzt mit Hebel 13,22: MM6GAL
Werbung

West Pharmaceutical Services News

14.05.25 - PR Newswire
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit PR Newswire
13.05.25 - PR Newswire
July 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WST
July 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WST PR Newswire
12.05.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
12.05.25 - PR Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST PR Newswire
12.05.25 - PR Newswire
WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
09.05.25 - PR Newswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class ...
09.05.25 - PR Newswire
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST PR Newswire
08.05.25 - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
08.05.25 - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
08.05.25 - PR Newswire
WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
07.05.25 - PR Newswire
Shareholder Alert: Robbins LLP Informs Investors of the West Pharmaceutical Services, Inc. Class Action Lawsuit
Shareholder Alert: Robbins LLP Informs Investors of the West Pharmaceutical Services, Inc. Class Action Lawsuit PR Newswire
07.05.25 - PR Newswire
West to Participate in Upcoming Investor Conferences
West to Participate in Upcoming Investor Conferences PR Newswire
06.05.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
06.05.25 - PR Newswire
WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit
WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit PR Newswire
24.04.25 - PR Newswire
West Announces Leadership Changes
West Announces Leadership Changes PR Newswire
24.04.25 - PR Newswire
West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
West Announces First-​Quarter 2025 Results, Increases Adjusted-​Diluted EPS Guidance and Declares Third-​Quarter 2025 Dividend PR Newswire
10.04.25 - PR Newswire
West to Host First-Quarter 2025 Conference Call
West to Host First-​Quarter 2025 Conference Call PR Newswire
05.03.25 - PR Newswire
West to Participate in Upcoming Investor Conferences
West to Participate in Upcoming Investor Conferences PR Newswire
20.02.25 - PR Newswire
West Announces Second-Quarter Dividend
West Announces Second-​Quarter Dividend PR Newswire
13.02.25 - Boersify
West Pharmaceutical Services Aktie: Verlust der Stabilität?
Die Aktie von West Pharmaceutical Services geriet am Donnerstag unter erheblichen Druck, nachdem das Unternehmen seine Prognose für das Jahr 2025 bekannt gab. Der ...

Newssuche

Videos

newspaper
10:20 Uhr +2,17%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »